Helus Pharma Inc.
HELP | NASDAQ
$10.60
-$0.11 (-1.03%)
At close: Oct 30, 2026, 4:00 PM ET
$10.76
+$0.16 (+1.51%)
Pre-market:
Nov 2, 2026, 4:57 AM ET
Fiscal Year Period Ending | FY 2026 Mar 31, 2026 | FY 2025 Mar 31, 2025 | FY 2024 Mar 31, 2024 | FY 2023 Mar 31, 2023 | FY 2022 Mar 31, 2022 | FY 2021 Mar 31, 2021 |
|---|---|---|---|---|---|---|
Revenue | -44.68M | 472.27K | n/a | 251.02K | 167.76K | 864K |
Cost of Revenue | 119.23K | 472.27K | n/a | 251.02K | 167.76K | 1.18M |
Gross Profit | -44.8M | n/a | n/a | n/a | n/a | -311K |
Operating Income | -141.68M | -143.15M | -78.84M | -51.52M | -63.84M | -31.04M |
Interest Income | 5.07M | 8.29M | 619K | 603K | 241K | 60K |
Pretax Income | -57.69M | -113.61M | -78.08M | -47.74M | -67.8M | -32.22M |
Net Income | -147.05M | -113.14M | -78.08M | -47.49M | -67.63M | -32.22M |
Selling & General & Admin | 56M | 88.24M | 46.47M | 26.03M | 46.25M | 27.42M |
Research & Development | 86.04M | 54.91M | 32.36M | 25.49M | 17.59M | 3.3M |
Other Expenses | -45.16M | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 96.87M | 143.15M | 78.84M | 51.52M | 63.84M | 30.72M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | 10K |
Selling & Marketing Expenses | 6.45M | 3.29M | 18.57M | 881K | 1.47M | 1.56M |
Cost & Expenses | 96.99M | 143.62M | 78.84M | 51.77M | 64.01M | 31.9M |
Income Tax Expense | 89.37M | -472.27K | n/a | -251.02K | -167.76K | n/a |
Shares Outstanding (Basic) | 34.8M | 20.22M | 20M | 4.88M | 4.4M | 2.63M |
Shares Outstanding (Diluted) | 34.8M | 20.22M | 20M | 4.88M | 4.4M | 2.63M |
EPS (Basic) | -4.23 | -5.59 | -3.91 | -9.73 | -15.36 | -12.24 |
EPS (Diluted) | -4.23 | -5.59 | -9.41 | -9.74 | -15.36 | -12.24 |
EBITDA | -141.56M | -142.94M | -78.41M | -51.27M | -63.67M | -30.99M |
EBIT | -141.68M | -143.15M | -78.84M | -51.52M | -63.84M | -31.04M |
Depreciation & Amortization | 120K | 211K | 424K | 251K | 168K | 49K |
Add to Watchlist
Select watchlists to add or remove HELP